Number of patient randomized in Credence trial
4401
Process of Balancing Glucose in the Body
Glucose Homeostasis
Number of US population with T2D
30 Million
Standard Laboratory test for Glucose
HGB A1C
Invokana
Canagliflozin
Duration of trial when Credence was stopped due to superior efficacy ( in years)
2.62 years
The key that unlocks the cells so that glucose can be utilized
Insulin
ratio of patients with Type 2 Diabetes that has CKD
1 in 3 patients
The normal Value for fasting Plasma glucose is ? while for whole blood is ?
60- 100 mg/dl
70-130 mg/dl
Trial on the Cardiovascular benefits of Invokana
Canvas
Mean baseline EGFR of patients in the credence study
56.3
Glucose is converted to ? when stored in the liver
Glycogen
amount of renal glucose a diabetic can hold before it spills through the urinary tract
240g
a chronic condition where the body's beta cells cannot produce insulin at all
Type 1 Diabetes
Trial on the renal benefits of Invokana
Credence
RRR of HHF result in Credence
39%
Enzyme secreted by the alpha cells that stimulates the conversion of glycogen to glucose
Glucagon
A1c reduction in Invokana monotherapy 26 wwek study from baseline with the 300mg dose at avg. A1c of 8?
1.03
Technically, hypoglycemia is defined as having glucose levels below_____mg/dl?
<70mg/dl
Invokana indication as a result of the Canvas and Credence Trials for ________
CV death
Difference between placebo and Invokana 100mg in EGFR per year in the progression of DKD
2.74mL/min/1.73m2per year
Process of converting non carbohydrates and proteins to glucose
Gluconeogenesis
4 stages of Pharmcokinetics
absorption
distribution
Metabolism
Excretion
The class of diabetes drugs to which Invokana belongs ?
SGLT2 INHIBITORS
The resource in Ipad that shows the managed care information of an account
Coverage Connect